News tagged with hemophilia
Gene therapy is a 'disruptive science' ready for commercial development
The time for commercial development of gene therapy has come. Patients with diseases treatable and curable with gene therapy deserve access to the technology, which has demonstrated both its effectiveness ...
Jan 24, 2012 |
5 / 5 (3) |
1
Preventive hemophilia A treatment reduces annual bleeding events and frequency of infusions
A Rush University Medical Center led international research team has announced that a treatment to prevent bleeding episodes in children with hemophilia A also is effective for adolescents and adults.
Jan 09, 2012 |
not rated yet |
0
|
Gene therapy helps patients with hemophilia B
(Medical Xpress) -- An experimental gene therapy technique boosted the production of a vital blood clotting factor in six people with hemophilia B, according to new research supported by the National Institutes of Health. ...
Dec 13, 2011 |
not rated yet |
0
New method boosts blood-clotting for hemophiliacs
Symptoms improved significantly in adults with the bleeding disorder hemophilia B following a single treatment with gene therapy developed by researchers at St. Jude Children's Research Hospital in Memphis and demonstrated ...
Dec 11, 2011 |
not rated yet |
0
|
Gene therapy shows promise as hemophilia treatment in animal studies
For the first time, researchers have combined gene therapy and stem cell transplantation to successfully reverse the severe, crippling bleeding disorder hemophilia A in large animals, opening the door to the development of ...
Nov 03, 2011 |
4 / 5 (1) |
0
Study first to confirm effectiveness and safety of new treatment for hemophilia
An international research team led by Dr. Cindy Leissinger of Tulane University School of Medicine, along with Dr. Alessandro Gringeri from the University of Milan, has found that a drug commonly used to treat bleeding events ...
Nov 02, 2011 |
not rated yet |
0
Study confirms males and females have at least one thing in common: Upregulating X
In a study published today in the journal Nature Genetics, a group of scientists including UNC biologist Jason Lieb, PhD, present experiments supporting a longstanding hypothesis that explains how males can survive with o ...
Oct 24, 2011 |
5 / 5 (2) |
1
|
Bioengineered protein shows preliminary promise as new therapy for hemophilia
A genetically engineered clotting factor that controlled hemophilia in an animal study offers a novel potential treatment for human hemophilia and a broad range of other bleeding problems.
Oct 23, 2011 |
not rated yet |
0
|
New NJIT book examines hemophilia and consequences of medical progress
The Bleeding Disease: Hemophilia and the Unintended Consequences of Medical Progress (John Hopkins University Press) is the new book by NJIT Associate Professor Stephen Pemberton. The book recounts the pr ...
Aug 18, 2011 |
not rated yet |
1
Genome editing improves blood clotting in mice with hemophilia B
(Medical Xpress) -- Scientists have used a gene therapy tool that acts like intelligent molecular scissors to correct the key gene defect in mice with hemophilia B, a disease that can lead to uncontrolled bleeding. The intervention ...
Jun 28, 2011 |
5 / 5 (2) |
0
Collaborative develops drug that may help hemophilia patients
A razor nick in the shower? A fall on a slippery floor? The average person simply calls it bad karma, but for people with hemophilia such episodes can cause prolonged blood loss.
Jun 27, 2011 |
not rated yet |
0
Gene therapy success depends on ability to advance viral delivery vectors to commercialization
Many gene therapy strategies designed to deliver a normal copy of a gene to cells carrying a disease-causing genetic mutation rely on a modified virus to transfer the gene product into affected tissues. One ...
May 18, 2011 |
not rated yet |
0
Studies document widespread, risky use clotting drug on non-hemophilia patients
In fact, the studies estimate that only 4 percent of the powerful drug's use in U.S. hospitals from 2000 through 2008 was for treating hemophilia patients, while an enormous 96 percent involved cases of heart surgery, trauma, ...
Medicine & Health / Medications
Apr 18, 2011 |
4 / 5 (1) |
0
Scientist discovers natural molecule indirectly prevents stable clot formation
A scientist from The Scripps Research Institute has identified a new role for a natural signaling molecule in preventing blood clot formation. The molecule could become a target for the development of novel and cost-effective ...
Feb 01, 2011 |
not rated yet |
0
|
Early safety results promising for Phase I/II trial of gene therapy treatment of hemophilia B
Investigators report no evidence of toxicity in the four hemophilia B patients enrolled to date in a gene therapy trial using a vector under development at St. Jude Children's Research Hospital and UCL (University College ...
Dec 06, 2010 |
not rated yet |
0
Haemophilia
Haemophilia (English pronunciation: /hiːməˈfɪliə/; also spelled hemophilia in North America, from the Greek haima αἷμα 'blood' and philia φιλος 'love') is a group of hereditary genetic disorders that impair the body's ability to control blood clotting or coagulation, which is used to stop bleeding when a blood vessel is broken. Haemophilia A (clotting factor VIII deficiency) is the most common form of the disorder, present in about 1 in 5,000–10,000 male births. Haemophilia B (factor IX deficiency) occurs in around 1 in about 20,000–34,000 female births.
Like most recessive sex-linked, X chromosome disorders, haemophilia is more likely to occur in males than females. This is because females have two X chromosomes while males have only one, so the defective gene is guaranteed to manifest in any male who carries it. Because females have two X chromosomes and haemophilia is rare, the chance of a female having two defective copies of the gene is very low, so females are almost exclusively asymptomatic carriers of the disorder. Female carriers can inherit the defective gene from either their mother or father, or it may be a new mutation. Although it is not impossible for a female to have haemophilia, it is unusual: a female with Haemophilia A or B would have to be the daughter of both a male haemophiliac and a female carrier, while the non-sex-linked Haemophilia C, which can affect either sex, is extremely rare.
Haemophilia lowers blood plasma clotting factor levels of the coagulation factors needed for a normal clotting process. Thus when a blood vessel is injured, a temporary scab does form, but the missing coagulation factors prevent fibrin formation, which is necessary to maintain the blood clot. A haemophiliac does not bleed more intensely than a person without it, but can bleed for a much longer time. In severe haemophiliacs even a minor injury can result in blood loss lasting days or weeks, or even never healing completely. In areas such as the brain or inside joints, this can be fatal or permanently debilitating.
For more information about Haemophilia, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.